Indaptus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INDP and other ETFs, options, and stocks.About INDP
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy.
CEOJeffrey A. Meckler
CEOJeffrey A. Meckler
Employees7
Employees7
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded
Founded
Employees7
Employees7
INDP Key Statistics
Market cap3.73M
Market cap3.73M
Price-Earnings ratio-0.07
Price-Earnings ratio-0.07
Dividend yield—
Dividend yield—
Average volume43.32K
Average volume43.32K
High today$2.22
High today$2.22
Low today$2.12
Low today$2.12
Open price$2.21
Open price$2.21
Volume15.64K
Volume15.64K
52 Week high$47.60
52 Week high$47.60
52 Week low$1.65
52 Week low$1.65
Stock Snapshot
As of today, Indaptus Therapeutics(INDP) shares are valued at $2.17. The company's market cap stands at 3.73M, with a P/E ratio of -0.07.
On 2025-12-05, Indaptus Therapeutics(INDP) stock moved within a range of $2.12 to $2.22. With shares now at $2.17, the stock is trading +2.4% above its intraday low and -2.4% below the session's peak.
Trading activity shows a volume of 15.64K, compared to an average daily volume of 43.32K.
Over the past 52 weeks, Indaptus Therapeutics(INDP) stock has traded between a high of $47.60 and a low of $1.65.
Over the past 52 weeks, Indaptus Therapeutics(INDP) stock has traded between a high of $47.60 and a low of $1.65.
People also own
Based on the portfolios of people who own INDP. This list is generated using Robinhood data, and it’s not a recommendation.